• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白(a)的部分氨基酸序列表明它与纤溶酶原同源。

Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.

作者信息

Eaton D L, Fless G M, Kohr W J, McLean J W, Xu Q T, Miller C G, Lawn R M, Scanu A M

出版信息

Proc Natl Acad Sci U S A. 1987 May;84(10):3224-8. doi: 10.1073/pnas.84.10.3224.

DOI:10.1073/pnas.84.10.3224
PMID:3472206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC304841/
Abstract

Apolipoprotein(a) [apo(a)] is a glycoprotein with Mr approximately equal to 280,000 that is disulfide linked to apolipoprotein B in lipoprotein(a) particles. Elevated plasma levels of lipoprotein(a) are correlated with atherosclerosis. Partial amino acid sequence of apo(a) shows that it has striking homology to plasminogen. Plasminogen is a plasma serine protease zymogen that consists of five homologous and tandemly repeated domains called kringles and a trypsin-like protease domain. The amino-terminal sequence obtained for apo(a) is homologous to the beginning of kringle 4 but not the amino terminus of plasminogen. Apo(a) was subjected to limited proteolysis by trypsin or V8 protease, and fragments generated were isolated and sequenced. Sequences obtained from several of these fragments are highly (77-100%) homologous to plasminogen residues 391-421, which reside within kringle 4. Analysis of these internal apo(a) sequences revealed that apo(a) may contain at least two kringle 4-like domains. A sequence obtained from another tryptic fragment also shows homology to the end of kringle 4 and the beginning of kringle 5. Sequence data obtained from two tryptic fragments show homology with the protease domain of plasminogen. One of these sequences is homologous to the sequences surrounding the activation site of plasminogen. Plasminogen is activated by the cleavage of a specific arginine residue by urokinase and tissue plasminogen activator; however, the corresponding site in apo(a) is a serine that would not be cleaved by tissue plasminogen activator or urokinase. Using a plasmin-specific assay, no proteolytic activity could be demonstrated for lipoprotein(a) particles. These results suggest that apo(a) contains kringle-like domains and an inactive protease domain.

摘要

载脂蛋白(a)[apo(a)]是一种糖蛋白,其分子量约为280,000,通过二硫键与脂蛋白(a)颗粒中的载脂蛋白B相连。血浆中脂蛋白(a)水平升高与动脉粥样硬化相关。apo(a)的部分氨基酸序列显示它与纤溶酶原具有显著的同源性。纤溶酶原是一种血浆丝氨酸蛋白酶原,由五个同源且串联重复的结构域(称为kringle结构域)和一个胰蛋白酶样蛋白酶结构域组成。apo(a)的氨基末端序列与kringle 4的起始部分同源,但与纤溶酶原的氨基末端不同源。apo(a)用胰蛋白酶或V8蛋白酶进行有限的蛋白水解,产生的片段被分离并测序。从这些片段中的几个获得的序列与纤溶酶原位于kringle 4内的391 - 421位残基高度同源(77 - 100%)。对这些apo(a)内部序列的分析表明,apo(a)可能至少包含两个kringle 4样结构域。从另一个胰蛋白酶片段获得的序列也显示与kringle 4的末端和kringle 5的起始部分同源。从两个胰蛋白酶片段获得的序列数据显示与纤溶酶原的蛋白酶结构域同源。其中一个序列与纤溶酶原激活位点周围的序列同源。纤溶酶原通过尿激酶和组织纤溶酶原激活剂切割特定的精氨酸残基而被激活;然而,apo(a)中的相应位点是一个丝氨酸,不会被组织纤溶酶原激活剂或尿激酶切割。使用纤溶酶特异性测定法,未检测到脂蛋白(a)颗粒的蛋白水解活性。这些结果表明,apo(a)包含kringle样结构域和一个无活性的蛋白酶结构域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/61b72b2f9895/pnas00275-0154-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/0bb5152bc105/pnas00275-0153-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/814795bb7521/pnas00275-0153-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/02c3912df083/pnas00275-0153-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/ae0974e9e808/pnas00275-0153-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/40973dd7e2c3/pnas00275-0153-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/135cfd579190/pnas00275-0154-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/40b79f3cbce6/pnas00275-0154-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/61b72b2f9895/pnas00275-0154-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/0bb5152bc105/pnas00275-0153-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/814795bb7521/pnas00275-0153-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/02c3912df083/pnas00275-0153-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/ae0974e9e808/pnas00275-0153-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/40973dd7e2c3/pnas00275-0153-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/135cfd579190/pnas00275-0154-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/40b79f3cbce6/pnas00275-0154-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4211/304841/61b72b2f9895/pnas00275-0154-c.jpg

相似文献

1
Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.载脂蛋白(a)的部分氨基酸序列表明它与纤溶酶原同源。
Proc Natl Acad Sci U S A. 1987 May;84(10):3224-8. doi: 10.1073/pnas.84.10.3224.
2
Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions.载脂蛋白(a)表型(570 kDa)与纤溶酶原的结构关系:同源kringle结构域由富含碳水化合物的区域连接。
Biol Chem Hoppe Seyler. 1987 Dec;368(12):1533-44. doi: 10.1515/bchm3.1987.368.2.1533.
3
Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system.载脂蛋白(a)抑制血管内皮细胞的体外管腔形成:对 Kringle V 和纤溶酶原激活系统作用的鉴定。
PLoS One. 2013;8(1):e52287. doi: 10.1371/journal.pone.0052287. Epub 2013 Jan 11.
4
Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.血浆中载脂蛋白(a) [Ip(a)] 浓度与载脂蛋白(a) [apo(a)] 基因中kringle IV/kringle V编码结构域的比例呈负相关。
J Clin Invest. 1989 Dec;84(6):2021-7. doi: 10.1172/JCI114395.
5
Comparison of ligand-binding sites of modeled apo[a] kringle-like sequences in human lipoprotein[a].人脂蛋白[a]中模拟的载脂蛋白[a] kringle样序列配体结合位点的比较
Arterioscler Thromb. 1993 May;13(5):758-70. doi: 10.1161/01.atv.13.5.758.
6
Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.载脂蛋白(a):赖氨酸结合位点和纤溶酶原激活物切割位点的结构-功能关系
Biol Chem. 2002 Jan;383(1):93-9. doi: 10.1515/BC.2002.009.
7
A structural assessment of the apo[a] protein of human lipoprotein[a].人脂蛋白[a]载脂蛋白[a]蛋白的结构评估
Proteins. 1992 Feb;12(2):188-99. doi: 10.1002/prot.340120212.
8
Convergent evolution of apolipoprotein(a) in primates and hedgehog.灵长类动物和刺猬中载脂蛋白(a)的趋同进化。
Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):11992-7. doi: 10.1073/pnas.94.22.11992.
9
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.人类载脂蛋白(a)的cDNA序列与纤溶酶原同源。
Nature. 1987;330(6144):132-7. doi: 10.1038/330132a0.
10
[Lipoprotein(a): characteristics of a special lipoprotein and its potential clinical significance].[脂蛋白(a):一种特殊脂蛋白的特性及其潜在临床意义]
Ther Umsch. 1990 Jun;47(6):475-81.

引用本文的文献

1
Lipoprotein(a)-Lowering Drugs: A Mini Review.降低脂蛋白(a)的药物:一篇小型综述。
J Clin Med Res. 2025 Apr;17(4):181-186. doi: 10.14740/jocmr6196. Epub 2025 Apr 11.
2
Role of Lipoprotein(a) Reduction in Cardiovascular Disease.脂蛋白(a)降低在心血管疾病中的作用。
J Clin Med. 2024 Oct 22;13(21):6311. doi: 10.3390/jcm13216311.
3
Digital droplet PCR versus quantitative PCR for lipoprotein (a) kringle IV type 2 repeat polymorphism genetic characterization.数字液滴 PCR 与定量 PCR 用于脂蛋白 (a) kringle IV 型 2 重复多态性遗传特征分析。

本文引用的文献

1
A gas-liquid solid phase peptide and protein sequenator.一种气-液-固相肽和蛋白质测序仪。
J Biol Chem. 1981 Aug 10;256(15):7990-7.
2
Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis.从聚丙烯酰胺凝胶中分离微克量蛋白质用于氨基酸序列分析。
Methods Enzymol. 1983;91:227-36. doi: 10.1016/s0076-6879(83)91019-4.
3
Studies onthe chemical nature of lysine-binding sites and on their localization in human plasminogen.
Biochim Biophys Acta. 1980 Oct 21;625(2):374-8. doi: 10.1016/0005-2795(80)90302-5.
J Clin Lab Anal. 2024 Mar;38(5):e24998. doi: 10.1002/jcla.24998. Epub 2024 Mar 5.
4
Lipoprotein(a) and diet-a challenge for a role of saturated fat in cardiovascular disease risk reduction?脂蛋白(a)与饮食-饱和脂肪在降低心血管疾病风险中的作用面临挑战?
Am J Clin Nutr. 2023 Jul;118(1):23-26. doi: 10.1016/j.ajcnut.2023.05.017. Epub 2023 May 11.
5
Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk.致动脉粥样硬化脂蛋白与他汀类药物残余心血管疾病风险。
Int J Mol Sci. 2022 Nov 4;23(21):13499. doi: 10.3390/ijms232113499.
6
RNA-based therapy in the management of lipid disorders: a review.基于RNA的疗法在脂质紊乱管理中的应用:综述
Lipids Health Dis. 2022 Apr 23;21(1):41. doi: 10.1186/s12944-022-01649-3.
7
Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.动脉粥样硬化性心血管疾病风险评估:美国预防心脏病学会临床实践声明
Am J Prev Cardiol. 2022 Mar 15;10:100335. doi: 10.1016/j.ajpc.2022.100335. eCollection 2022 Jun.
8
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.脂蛋白(a):一种与遗传相关的、因果性的、普遍存在的动脉粥样硬化性心血管疾病风险因素:美国心脏协会的科学声明。
Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60. doi: 10.1161/ATV.0000000000000147. Epub 2021 Oct 14.
9
Performance evaluation of five lipoprotein(a) immunoassays on the Roche cobas c501 chemistry analyzer.罗氏cobas c501化学分析仪上五种脂蛋白(a)免疫测定法的性能评估
Pract Lab Med. 2021 Mar 24;25:e00218. doi: 10.1016/j.plabm.2021.e00218. eCollection 2021 May.
10
High resolution structure of human apolipoprotein (a) kringle IV type 2: beyond the lysine binding site.人载脂蛋白(a)kringle IV 型 2 的高分辨率结构:赖氨酸结合位点之外。
J Lipid Res. 2020 Dec;61(12):1687-1696. doi: 10.1194/jlr.RA120001023. Epub 2020 Sep 9.
4
The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain.人尿中高分子量尿激酶的一级结构。A链的完整氨基酸序列。
Hoppe Seylers Z Physiol Chem. 1982 Oct;363(10):1155-65. doi: 10.1515/bchm2.1982.363.2.1155.
5
Plasminogen-binding lipoprotein: isolation and characterization of a plasma very low density lipoprotein which co-chromatographs with plasminogen on lysine-sepharose.
Thromb Res. 1983 Sep 15;31(6):863-74. doi: 10.1016/0049-3848(83)90117-2.
6
Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli.人组织型纤溶酶原激活剂cDNA在大肠杆菌中的克隆与表达。
Nature. 1983 Jan 20;301(5897):214-21. doi: 10.1038/301214a0.
7
Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor.脂蛋白(a)进入培养的成纤维细胞的过程独立于质膜低密度脂蛋白受体。
Clin Genet. 1981 Nov;20(5):352-62. doi: 10.1111/j.1399-0004.1981.tb01047.x.
8
Uptake of Lp (a) lipoprotein by cultured fibroblasts.培养的成纤维细胞对脂蛋白(a)的摄取
Biochem Biophys Res Commun. 1981 Sep 30;102(2):636-9. doi: 10.1016/s0006-291x(81)80179-9.
9
Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins.人血浆脂蛋白(a)的异质性。脂蛋白亚类及其载脂蛋白的分离与鉴定。
J Biol Chem. 1984 Sep 25;259(18):11470-8.
10
Human plasma lipoprotein [a]. Structural properties.人血浆脂蛋白[a]。结构特性。
J Biol Chem. 1983 Apr 10;258(7):4582-9.